Design, Synthesis and Biochemical Evaluation of Novel Selective Estrogen Receptor Ligand Conjugates Incorporating an Endoxifen-Combretastatin Hybrid Scaffold-Reference-Cited by-同舟云学术

Design, Synthesis and Biochemical Evaluation of Novel Selective Estrogen Receptor Ligand Conjugates Incorporating an Endoxifen-Combretastatin Hybrid Scaffold

Published:2016-07-20 Issue:3 Volume:4 Page:15
ISSN:2227-9059
Container-title:Biomedicines
language:en
Short-container-title:Biomedicines

Author:

Keely Niall,Carr Miriam,Yassin Bassem,Ana Gloria,Lloyd David,Zisterer Daniela,Meegan Mary

Publisher

MDPI AG

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)

Link

http://www.mdpi.com/2227-9059/4/3/15/pdf

Reference83 articles.

1. Structure–function relationship of estrogen receptor α and β: Impact on human health

2. Anti-oestrogenic prevention of breast cancer — the make or break point

3. Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 1. Receptor Interactions

4. Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents

5. Advances in the Science of Estrogen Receptor Modulation

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of covalently linked tamoxifen hybrids for cancer treatment: recent update;RSC Medicinal Chemistry;2024

2. Synthesis and Pro-Apoptotic Effects of Nitrovinylanthracenes and Related Compounds in Chronic Lymphocytic Leukaemia (CLL) and Burkitt’s Lymphoma (BL);Molecules;2023-12-14

3. New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAF ^V600E and EGFR inhibitors celecoxib analogs: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-12-07

4. Green chemistry approach towards Piperazine: anticancer agents;Journal of Molecular Structure;2023-11

5. Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands;Pharmaceutics;2022-12-26